josamycin;Josamycin solution;Leucomycin A3;carbomycin B;EN 141;Iosalide;Jomybel;Josacine;Josamina;Vilprafen;Wilprafen;YL-704A3;Kitasamycin A3;Turimycin A5;C12662;Josamycin;Josamycin, >=98.0% (UV);CHEMBL224436;[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyl-tetrahydropyran-3-yl]oxy-4-hydroxy-2,4-dimethyl-tetrahydropyran-3-yl] 3-methylbutanoate;[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-;D01235;JOSAMYCIN [INN];16846-24-5;Stereoisomer of 4-(acetyloxy)-6-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-(3-methyl-1-oxobutyl)-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-diene-7-acetaldehyde;Josamycin (JP17/USAN/INN);Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4'-isovalerate;CS-0013975;Leucomycin V 3-acetate 4b-(3-methylbutanoate);Josamycine [INN-French];EN-141;Kitasamycin A3;Leucomycin A3;Turimycin A5;Josamycin for peak identification, European Pharmacopoeia (EP) Reference Standard;Josamycin (TN);Josamycin, European Pharmacopoeia (EP) Reference Standard;6-{6-[3-Acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl-6-oxa-5-oxo-16-(2-oxoethyl)cyclohexadeca-9,11-dienyloxy]-4-(dimethylamino)-5-hydroxy-2-methylperhydro-2H-pyran-3-yloxy}-4-hydroxy-2,4-dimethylperhydro-2H-pyran-3-yl 3-methylbutanoate;Josamycin; (4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-l-ribo-hexopyranosyl]-3-(dimethylamino)-ss-d-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2-one;Josamycinum;Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate);NSC122223;HV13HFS217;leucomycin V 3-acetate 4(B)-(3-methylbutanoate);JOSAMYCIN [USAN];[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate;Josamicina;JOSAMYCIN [MART.];SCHEMBL132829;GTPL12924;JOSAMYCIN [MI];hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate;Leucomycin A3 (>90%);Antibiotic yl-704 A3;Josamycine;Josamicina [INN-Spanish];Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate);JM;Leucomycin V 3-acetate 4(beta)-(3-methylbutanoate);leucomycin V 3-acetate 4beta-(3-methylbu...